Global Synthetic Genes Market to Reach $23.4 Billion by 2030
The global market for Synthetic Genes estimated at US$6 Billion in the year 2022, is projected to reach a revised size of US$23.4 Billion by 2030, growing at a CAGR of 18.5% over the analysis period 2022-2030. Pharmaceuticals & Diagnostics, one of the segments analyzed in the report, is projected to record 19.1% CAGR and reach US$9.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Chemicals segment is readjusted to a revised 15.4% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.6 Billion, While China is Forecast to Grow at 25.2% CAGR
The Synthetic Genes market in the U.S. is estimated at US$1.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6.1 Billion by the year 2030 trailing a CAGR of 25.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.7% and 16% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 14.6% CAGR.Select Competitors (Total 34 Featured) -
- Active Motif
- BASF AG
- Bayer AG
- Cargill Inc.
- Dow, Inc.
- DuPont de Nemours, Inc.
- Glaxosmithkline Plc
- Merck KGAA
- Novartis Pharma AG
- Pfizer, Inc.
- Thermo Fisher Scientific, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its 'bumpy' reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Active Motif
- BASF AG
- Bayer AG
- Cargill Inc.
- Dow, Inc.
- DuPont de Nemours, Inc.
- Glaxosmithkline Plc
- Merck KGAA
- Novartis Pharma AG
- Pfizer, Inc.
- Thermo Fisher Scientific, Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 89 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 6 Billion |
Forecasted Market Value ( USD | $ 23.4 Billion |
Compound Annual Growth Rate | 18.5% |
Regions Covered | Global |